Prospective longitudinal evaluation of lung function during the first year of life after extracorporeal membrane

Ward Hofhuis1, Manon N Hanekamp, Hanneke Ijsselstijn

  • 1Department of Pediatrics, Division of Pediatric Respiratory Medicine, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, The Netherlands.

Insights

Infants receiving extracorporeal membrane oxygenation (ECMO) show normal lung volumes in their first year. Forced expiratory flow remains stable but below average, suggesting ECMO may protect lung function in critically ill neonates.

Area of Science:

  • Neonatal care
  • Pediatric pulmonology
  • Extracorporeal membrane oxygenation (ECMO) research

Background:

  • Longitudinal data on infant lung function post-ECMO is limited.
  • Understanding the long-term respiratory impact of ECMO is crucial for neonatal care.

Purpose of the Study:

  • To track lung function in infants during the first year after ECMO.
  • To explore links between lung function and perinatal factors in this cohort.

Main Methods:

  • Prospective longitudinal cohort study design.
  • 64 infants undergoing ECMO for various conditions were evaluated at 6 and 12 months.
  • Lung function measured included functional residual capacity and forced expiratory flow.

Main Results:

  • Infants maintained normal lung volumes (z-scores near 0) at 6 and 12 months.
  • Forced expiratory flow was consistently below average (z-scores around -1.1 to -1.2, p < .001).
  • Infants with congenital diaphragmatic hernia showed significantly above-normal lung volumes at 12 months.

Conclusions:

  • ECMO-treated infants exhibit normal lung volumes and stable, albeit reduced, expiratory flows within the first year.
  • ECMO may mitigate lung injury from mechanical ventilation or preserve lung function in neonates.
  • Further research is needed to fully elucidate the protective mechanisms of ECMO on neonatal lung development.
Abstract